News
The Food and Drug Administration has paused distribution of the gene therapy Elevidys following the death of a third patient ...
2h
NewsNation on MSNParents urge FDA to restore gene therapy after distribution pauseA recent FDA investigation has paused further distribution of Elevidys, following reports of at least three patient deaths.
Sarepta Therapeutics now trades at book value with strong cash and cost-cutting plans, while ELEVIDYS may regain broader use.
Breakthrough as two FDA-approved drugs are found to reverse Alzheimer’s — including restoring memory
Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.
1d
The Hearty Soul on MSNParkinson's Discovery Suggests We Could Have an FDA-Approved Treatment AlreadyParkinson's is a progressive neurodegenerative disease that is currently incurable. It is typically only diagnosed once ...
If the Supreme Court gets involved, it could set national precedent for states to ban medications approved by the FDA.
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
Four months after giving Eli Lilly’s Alzheimer’s disease treatment a thumbs-down, Europe’s Committee for Medicinal Products for Human Use (CHMP) has ...
A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), a chronic inflammatory disease that affects nearly 3 million people ...
Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...
A study finds firefighters have a 62% higher risk of developing esophageal cancer compared to the general population. There's ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results